Achieve Life Sciences is trading at $6.43 (+5.41%) today, extending recent gains amid a broader risk-on market sentiment.
- The stock continues to build on momentum from the previous session despite a lack of new company-specific announcements or regulatory catalysts.
- The upward move appears to be driven by general market strength rather than internal corporate developments or earnings results.